Efficacy and safety of rituximab in patients with PLA2R associated membranous nephropathy and resolved HCV infection

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
Efficacy and safety of rituximab in patients with PLA2R associated membranous nephropathy and resolved HCV infection ; volume:14 ; number:1 ; day:9 ; month:9 ; year:2024 ; pages:1-8 ; date:12.2024
Scientific reports ; 14, Heft 1 (9.9.2024), 1-8, 12.2024

Creator
Li, Xiaodan
Song, Dongxu
Hao, Yingxuan
Ren, Mingjing
Guo, Yanhong
Zhao, Huayan
Wang, Yulin
Tang, Lin
Contributor
SpringerLink (Online service)

DOI
10.1038/s41598-024-72082-y
URN
urn:nbn:de:101:1-2411232111487.322071956586
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:31 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Li, Xiaodan
  • Song, Dongxu
  • Hao, Yingxuan
  • Ren, Mingjing
  • Guo, Yanhong
  • Zhao, Huayan
  • Wang, Yulin
  • Tang, Lin
  • SpringerLink (Online service)

Other Objects (12)

Rituximab may affect T lymphocyte subsets balance in primary membranous nephropathy

Rituximab may affect T lymphocyte subsets balance in primary membranous nephropathy

Lupus Membranous Nephropathy

Lupus Membranous Nephropathy

Perspectives in membranous nephropathy

Perspectives in membranous nephropathy

Rituximab Treatment in a Patient with Kimura Disease and Membranous Nephropathy: Case Report

Rituximab Treatment in a Patient with Kimura Disease and Membranous Nephropathy: Case Report

Monthly mini-dose rituximab for primary anti-PLA2R-positive membranous nephropathy: a personalized approach

Monthly mini-dose rituximab for primary anti-PLA2R-positive membranous nephropathy: a personalized approach

C4d immunohistochemistry in membranous nephropathy

C4d immunohistochemistry in membranous nephropathy

Treatment of Membranous Nephropathy in Chinese Patients: Comparison of Rituximab and Intravenous Cyclophosphamide with Steroids

Treatment of Membranous Nephropathy in Chinese Patients: Comparison of Rituximab and Intravenous Cyclophosphamide with Steroids

Membranous nephropathy: a retrospective observational study of membranous nephropathy in north east and central London

Membranous nephropathy: a retrospective observational study of membranous nephropathy in north east and central London

Antigen-specific therapies of membranous nephropathy

Antigen-specific therapies of membranous nephropathy

Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series

Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series

Advances in Pathogenesis of Idiopathic Membranous Nephropathy

Advances in Pathogenesis of Idiopathic Membranous Nephropathy

Horseshoe kidney with PLA2R-positive membranous nephropathy

Horseshoe kidney with PLA2R-positive membranous nephropathy

Related objects